What’s the hottest biotech R&D field in ven­ture in­vest­ing?

If you guessed can­cer with­out even think­ing about it, you get a gold End­points star. But just how much hot­ter is on­col­o­gy com­pared to every oth­er field in bio­phar­ma R&D?

“On­col­o­gy grabs the largest per­cent­age of ven­ture-backed ex­its ver­sus any oth­er in­di­ca­tion in bio­phar­ma, both in num­ber of deals and in deal val­ue,” notes Jonathan Nor­ris, the man­ag­ing di­rec­tor of Sil­i­con Val­ley Bank’s health­care prac­tice.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.